Albert Szent-Gy.rgyi Prize for Progress in Cancer Research to Harvard's Harold F. Dvorak, M.D.
3rd Nov 2005, 15:08 GMT
The National Foundation for Cancer Research (NFCR) announced today that Harold F. Dvorak, M.D., Mallinckrodt Professor of Pathology at Harvard Medical School and Chief of the Department of Pathology at Beth Israel Deaconess Medical Center, has been awarded the inaugural Albert Szent-Gy.rgyi Prize for Progress in Cancer Research.
Albert Szent-Gy.rgyi Prize for Progress in Cancer Research to Harvard's Harold F. Dvorak, M.D. related news:
- Harold Pinter, the 75-year-old English playwright seen here ... — Nobel Prize Recipients on Yahoo! News Photos
- Harold Pinter is unsure whether the Nobel committee gave him ... — Nobel Prize Recipients on Yahoo! News Photos
- ECCO 13 - One voice, one vision needed to overcome cancer in Europe — Medical News Today RSS/XML Feed
- $50 mil. gift from the Simmons to expand cancer care, clinical research programs at UT Southwestern — EurekAlert! - Medicine and Health
- British playwright Harold Pinter, talking to the press outside ... — Nobel Prize Recipients on Yahoo! News Photos
- British playwright Harold Pinter smiles outside his home in ... — Nobel Prize Recipients on Yahoo! News Photos
- Harvard University professor Graham Allison (L) listens as Mohamed ... — Nobel Prize Recipients on Yahoo! News Photos
- Harold Pinter wins Nobel — iVillage Video News: All Things Entertainment
- Harold Pinter, Britain's greatest living playwright, wondered ... — Nobel Prize Recipients on Yahoo! News Photos
- Cancer Research Center gets $10M to start project — The Honolulu Advertiser: Local News
Latest news from EurekAlert! - Cancer:
- Targeted cancer drugs may work by disrupting balance of cellular signals
- Studies examine colorectal cancer screening rates
- Higher red meat intake may increase risk for certain breast cancers
- U-M researchers use nanoparticles to target brain cancer
- 'Trojan Horse' agent halts bone metastasis in mice
- Increased patient demand for prostate test has serious implications for cancer services
- Novel regulatory mechanism identified for key tumor suppressor p53